Latest AI and machine learning research in liver transplantation for healthcare professionals.
Hepatitis B virus (HBV) infection causes approximately one million deaths annually and remains a maj...
Glioblastoma (GBM), the most aggressive primary brain tumor in adults, exhibits profound treatment r...
Glioblastoma (GBM), the most aggressive primary brain tumor, has a median survival of approximately ...
Although therapeutic drugs targeting gasdermin (GSDM)-mediated pyroptosis have made remarkable progr...
The progression of lung adenocarcinoma (LUAD) from precancerous lesions to invasive carcinoma entail...
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a highly prevalent condition cha...
Identifying immunosuppressed patients using structured data can be challenging. Large language model...
Background and aims. The first direct-acting antivirals (DAAs) to treat the viral hepatitis C (HCV) ...
Large language models (LLMs) have emerged as transformative technologies, revolutionizing natural la...
Annotation of liver biopsies, for disease staging is increasingly aided by digital pathology, howeve...
Despite long-standing success of hematopoietic stem cell transplantation (HSCT) in the treatment of ...
Hepatitis, a disease characterized by inflammation of the liver, is a leading global health challeng...
The critical need for precise risk stratification in severe liver cirrhosis is underscored by its su...
Chronic kidney disease (CKD) affects millions worldwide and often progresses to end-stage renal dise...
Cardiac allograft rejection (CAR) remains the leading cause of early graft failure after heart trans...
Lung transplantation remains the only definitive treatment for patients with end-stage respiratory f...
Sepsis-induced immunosuppression, characterized by lymphopenia, is associated with adverse outcomes....
Optimizing immunosuppressive therapy remains central to improving long-term outcomes after kidney tr...
INTRODUCTION: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global h...
BACKGROUND: At present, there are no specialized models for predicting mortality risk in patients wi...
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a heterogeneous disease caused b...